Skip to main content

Primary cutaneous actinomycosis: a diagnosis consideration in people living with HIV/AIDS

Abstract

Background

Owing to similar clinical presentations, as of cutaneous disease of different etiologies, and extreme rarity in the global incidence; primary cutaneous actinomycosis often remains as diagnostic challenges.

Case presentation

Herein, we describe a case of primary cutaneous actinomycosis, erroneously treated as cutaneous tuberculosis, in a patient living with AIDS. On clinical examination, the characteristic lesion, resembling cutaneous tuberculosis, observed on the dorsum of a left leg. No other lesion elsewhere on the body was observed, however. Cytological examinations of the stabbed biopsy were negative for malignant cells; although hyper-keratosis and mild-acanthosis of epidermis, acute inflammatory infiltrates comprising plasma cell, macrophages and neutrophils were observed in the upper and mid dermis. The pus aspirated from lesion grew a molar tooth, adherent colonies in microaerophilic condition. Further, identifications and susceptibility pattern against recommended antibiotics were assessed as per the CLSI (Clinical and Laboratory Standard Institute) guidelines. Subsequently, the case was then, diagnosed as primary cutaneous actinomycosis. Radiographic imaging of abdomen and lungs were normal; no feature of disseminated actinomycosis seen. Penicillin G followed by Penicillin V, was prescribed for 12 months. The patient underwent progressive changes and no relapse noted on periodic follow-up.

Conclusion

The case underscores cutaneous actinomycosis requires a diagnosis consideration, especially in People Living with HIV/AIDS (PLHA), where myriad of opportunistic cutaneous infections are common.

Background

Actinomycosis is an unusual sub-acute or chronic suppurative and granulomatous bacterial infection characterized by multiple abscesses, tissue fibrosis, and the formation of sinuses and fistulae [1]. The culprits ensuing the infection, Actinomyces spp., are the aerobic or micro-aerophilic filamentous gram-positive bacilli which basically colonized in oropharynx, gastrointestinal tract and uro-genital tract [1,2,3]. Despite, the indigenous habitat of the pathogen, a few cases of actinomycosis inflicting bone and joints, skin and soft tissue, CNS, respiratory tract, digestive tract can be found on a literature search [1, 3]. Of reported clinical manifestations, disseminated forms, originating from other colonized sites, are likely occurring; however, primary actinomycosis involving only principle site i.e. extremities is extremely rare [3,4,5].

It is somewhat surprising, the reported incidence of actinomycosis in PLHA has remained low; nevertheless, the persistent impairment in both cellular and humoral immunity are more obvious, due to HIV (human immunodeficiency virus) [6]. The reason for this is not clear, nonetheless, can be speculated due to misdiagnosis. The misdiagnosis often occurs, particularly in PLHA where myriads of other infections are more common, owing to similar indolent and non-specific clinical manifestations of actinomycosis which masquerades as infections of other etiologies [6, 7]. With this backdrop, herein, we report a case of primary cutaneous actinomycosis, mimicking as cutaneous tuberculosis, in a patient living with HIV/AIDS.

Case presentation

A 42-year-old farmer presented to the Dermatology out-patient department (OPD), Sumeru Hospital, a tertiary care hospital in Kathmandu, with the complaint of a large hard lesion that with time multiplied gradually and had multiple openings discharging pus. He had lived with HIV for 6 years and was from middle-class socio-economic status. Besides, no previous history of systemic illness and major surgical interventions was described. Although, he reported being bitten by own dog earlier 1 month ago on same foot, before the lesion first appears. Based upon the clinical presentations and unresolved lesion with extended courses of antimicrobial therapy (cloxacillin), the previous diagnosis was made as cutaneous tuberculosis, from the local hospital; was treated with anti-tubercular treatment (ATT) for 4 months. Inconsistently, the lesions continued to progress with pus and bloody discharges. On clinical examination, the patient had a large plaque-like lesion about 10 cm × 6 cm overlying skin with papules and nodules on the dorsum of a left leg (Fig. 1). Over the lesion, multiple discharging sinuses draining sero-sanguinous fluid were scattered. No other lesion elsewhere on the body was observed, however. His neurovascular status of the foot was normal with no associated regional lymphadenopathy. Scrutinizing these clinical presentations and clinical history, the differential diagnosis of rifampicin-resistant cutaneous tuberculosis, mycetoma/madura foot, and cutaneous nocardiosis was made.

Fig. 1
figure1

Large plaque-like lesion about 10 cm × 6 cm with papules and nodules; multiple discharging sinuses draining sero-sanguinous fluid

Investigation

Histopathological examination, of stabbed biopsy, revealed hyper-keratosis and mild-acanthosis of the epidermis, while acute inflammatory infiltrates comprising plasma cell, macrophages and neutrophils were observed in the upper and mid dermis. Peripheral blood smear portrayed normal cell morphology, normal hemoglobin level (13 gm/dL); while, WBC (12,400/mL) and platelets (4, 15,200/µL) count were slightly elevated. Serological test for HBsAg and HCV were non-reactive; although, HIV was positive (ELISA) with drop off CD4 count 128 cell/µL.

The presumptive identification of etiologies was done with gram staining from the lesion which revealed branching filamentous gram-positive bacteria suggestive Actinomyces spp. (Fig. 2). As of further microbiological approaches, the cultured pus aspirate grew molar tooth shaped adherent colonies after 72 h of incubation at 36 °C on blood agar and chocolate agar in presence of ambient air, 5% Co2 (Figs. 3, 4). Since molecular analysis and sequencing was not accessible in our laboratory setting; further, identification of the isolate, Actinomyces israeli, was done with standard microbiological culture methods as recommended by American Society for Microbiology based upon phenotypic characteristics and biochemical interpretations [8]. In brief, colony morphology (chalky, matt, dry, crumbly, adherent in appearances; 0.5–2.0 mm in diameter with fine intertwining, branching filaments); in-house set of biochemical test: pigmentation (negative), catalase (negative), nitrate reduction (positive), hydrolysis of urea (negative) while esculin (positive), production of α-glucosidase and β-galactosidase (positive) while α-fucosidase and β-NAG (negative), fermentation of arabinose, maltose, raffinose, rhamnose, sucrose, xylose, trehalose (positive) while mannitol (negative). The antimicrobial susceptibility testing was done by modified Kirby-baur disc diffusion method on blood agar against commercially prepared antibiotic disks (Hi-Media Laboratories, Pvt, limited, India) in compliance with Clinical Laboratory Standards Institute (CLSI). The isolate was sensitive to penicillin G, amoxicillin, ceftriaxone, meropenem, doxycycline, linezolid, clindamycin, while ciprofloxacin and erythromycin were found resistant. Gene Xpert testing from the pus sample was negative for Mycobacterium tuberculosis with no associated resistant gene. No fungal elements grew from the pus aspirate; blood and urine sample were sterile.

Fig. 2
figure2

Gram stain: gram positive branching filamentous bacteria suggestive Actinomyces spp. (×1000 orginal magnification)

Fig. 3
figure3

Colonial morphology of Actinomyces israelii on blood agar: whitish chalky adherent colonies with molar tooth appearance

Fig. 4
figure4

Colonial morphology of Actinomyces israelii on chocolate agar: whitish chalky adherent colonies with molar tooth appearance

Additionally, CT scan of abdomen and chest was done to rule-out possible disseminated actinomycosis; conversely, no abnormalities detected. In view of clinical manifestations and investigation reports, a diagnosis of primary cutaneous actinomycosis was made in HIV positive patient. After then, anti-tubercular therapy was discontinued and the patient was treated with intravenous benzylpenicillin (Penicillin G) for 6 weeks followed by oral phenoxymethylpenicillin (Penicillin V) for another 6 weeks.

Treatment

The patient was treated with penicillin G–24 million U/d intravenous by continuous infusion for 6 weeks; and then shifted to oral penicillin V for another 6 weeks then to follow. The oral penicillin was continued up to 12 months.

Outcomes and follow-up

He has now completed 3 months of antimicrobial therapy; has undergone progressive changes—flattening and regression of the indurated lesion observed—no sign of relapse noted (Fig. 5). The oral penicillin V continued for a year to limit the possible late relapse. Now, the lesion healed completely without recur.

Fig. 5
figure5

Flattening and regression of the indurated lesion after 3 months of antimicrobial therapy (Penicillin)

Literature search

All the relevant information presented in table and literature review included in the manuscript was collected via searching Google, Pub Med/NCBI and other similar databases from 1986 to 2017. Key search terms were actinomycosis, HIV/AIDS, diagnosis consideration and clinical management (Table 1) [9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,25].

Table 1 Summary of actinomycosis and its clinical management in patient living with HIV/AIDS patient, reported in English-language literature

Discussion

The emergence of HIV and the onset of AIDS epidemic have been associated with a myriad of opportunistic cutaneous infections; however, the cutaneous actinomycosis is out-of-the limelight from the differential diagnosis. The masquerading clinical presentations as cutaneous tuberculosis, fungal infections, malignancies and other systemic infections, difficult in vitro cultivation of the pathogen, and non-specific radiological picture are commonly associated outfits leading misdiagnosis [6]. In our case, the primordial diagnosis was made as cutaneous tuberculosis, based upon the clinical presentations and unresolved lesion with extended courses of antimicrobial therapy (cloxacillin). Further, unresolved lesion, even after the anti-tubercular therapy implies a differential diagnosis of rifampicin-resistant cutaneous tuberculosis, mycetoma/madura foot, and cutaneous nocardiosis.

Relating the endogenous habitat or colonization of the pathogen, Actinomyces israelii, the primary cutaneous actinomycosis of a lower extremity is extremely rare; associated either with post-traumatic exposure or direct implantation of the pathogen via animal, insects or human bites [26,27,28]. Linking the common ground of infection acquisition, probably the pathogen could have inoculated from the dog bites since no other clinical history suggesting sourced pathogen reported. No detectable extra-cutaneous lesions and radiological picture portentous to the dissemination were observed.

Moreover, difficulties in in vitro cultivation of the pathogen attribute further diagnostic challenges; since, longer incubation, up to 10 days, is obligatory prior to be reported as sterile [3, 29]. Earlier, the presumptive diagnosis could have made at least with gram staining in the local hospital; despite, relying only upon clinical manifestations; which inturn could prevent the erroneous diagnosis and treatment. Needless to say, but it is the ground reality of clinical practice, in developing countries like Nepal. The identification of the etiology, Actinomyces israelii, was done by standard microbiological culture methods as recommended by the American Society for Microbiology based upon: phenotypic characteristics of the isolate, its antimicrobial susceptibility pattern against antibiotics, extended incubation period and biochemical interpretations; sequencing of 16SrRNA, however, was not available in our setting [8, 29, 30]. Therefore, prior to starting the antimicrobial therapy, a high index of clinical suspicion together with close collaboration with microbiological interpretations is of utmost importance, for successful outcomes.

For successful management and treatment in cutaneous actinomycosis—limiting possible late relapse: early detection of the pathogen, recommended surgical debridement along with the appropriate selection of antimicrobial therapy, correct dosing, and treatment duration; are crucial [31, 32]. High-dose of penicillin over a prolonged period, 6 months to 1 year, is presumed as the drug of choice for all forms of actinomycosis [1, 6, 17, 27, 32]. As an alternative to penicillin, if the patient is hypersensitive to penicillin or if etiologies are resistant to penicillin, the antibiotics such as clindamycin, erythromycin, tetracycline, doxycycline, ceftriaxone, and chloramphenicol could be opted [32,33,34]. However, the clinicians must be cautious while opting the antibiotics: metronidazole, aminoglycosides, aztreonam, co-trimoxazole (TMP–SMX), penicillinase-resistant penicillins (e.g., methicillin, nafcillin, oxacillin, cloxacillin), and cephalexin, since these antibiotics possess nearly no activity against Actinomyces spp. [33.]. Unfolding to our case, no progressive changes on the lesion occurred; since as implicated antibiotic therapy i.e. cloxacillin was opted, initially. Although, on shifting to penicillin the patient undergone progressive changes; lesion healed subsequently and no relapse noted. Therefore, it is mandatory that the therapeutic regimen should be customized for each patient depending upon the susceptibility of the pathogen against the antibiotics.

The adverse reaction, nevertheless, owing to prolonged and high dose of penicillin therapy, are common including pseudomembranous colitis, interstitial nephritis, epigastric distress, urticarial, leukopenia, allergic reactions, eosinophilia, and super-infection [35]. No such side effects were found to be associated in our case, however. The patient reported a few episodes of nausea, vomiting, and diarrhea during 12 months of medication as minimal side effects.

Conclusion

In clinical practice, the cutaneous actinomycosis often outfits with diagnostic challenges, owing to the multifaceted clinic-pathological features as of cutaneous infection with different etiology, and inherent difficulty in in vitro cultivating. Therefore, cutaneous actinomycosis requires a diagnosis consideration, especially in PLHA, where myriad of opportunistic cutaneous infections are common.

Availability of data and materials

All data generated or analyzed during this study are included in this published article.

Abbreviations

ATT:

anti-tubercular treatment

CLSI:

Clinical and Laboratory Standard Institute

CT:

computerized tomography

HBsAg:

hepatitis B surface antigen

HCV:

hepatitis C Virus

HIV:

human immunodeficiency virus

PLHA:

people living with HIV/AIDS

TMP–SMX:

trimethoprim–sulfamethoxazole

References

  1. 1.

    Lustig S. Actinomycosis: etiology, clinical features, diagnosis, treatment, and management. Infect Drug Resist. 2014;7:183–97.

    PubMed  PubMed Central  Google Scholar 

  2. 2.

    Sabbe LJ, Van De Merwe D, Schouls L, Bergmans A, Vaneechoutte M, Vandamme P. Clinical spectrum of infections due to the newly described. J Clin Microbiol. 1999;37(1):8–13.

    CAS  PubMed  PubMed Central  Google Scholar 

  3. 3.

    Könönen E, Wade WG. Actinomyces and related organisms in human infections. Clin Microbiol Rev. 2015;28(2):419–42.

    Article  Google Scholar 

  4. 4.

    Inamadar AC, Palit A. Study Primary cutaneous nocardiosis: a case study and review. Send to Indian J Dermatol Venereol Leprol. 2003;69(6):386–91.

    CAS  Google Scholar 

  5. 5.

    Sonam Sharma RS, Sharma SC. Primary cutaneous actinomycosis of the lower extremity: a clinical. J Orthop Surg Rehabil. 2017;1(2):1–4.

    Google Scholar 

  6. 6.

    Chaudhry SI, Greenspan JS. Actinomycosis in HIV infection: a review of a rare complication. Int J STD AIDS. 2000;11(6):349–55.

    CAS  Article  Google Scholar 

  7. 7.

    D’Agoastino M, Al Habeeb A, Ghazarian D. Cutaneous actinomycosis: the great mimicker. J Clin Pathol. 2009;62(8):765–6.

    Article  Google Scholar 

  8. 8.

    Sarkonen N, Könönen E, Summanen P, Könönen M, Jousimies-Somer H. Phenotypic identification of Actinomyces and related species isolated from human sources. J Clin Microbiol. 2001;39(11):3955–61.

    CAS  Article  Google Scholar 

  9. 9.

    Yeager BA, Hoxie J, Weisman RA, Greenberg MS, Bilaniuk LT. Actinomycosis in the acquired immunodeficiency syndrome-related complex. Arch Otolaryngol Neck Surg. 1986;112(12):1293–5.

    CAS  Article  Google Scholar 

  10. 10.

    Watkins KV, Richmond AS, Langstein IM. Nonhealing extraction site due to Actinomyces naeslundii in patient with AIDS. Oral Surg Oral Med Oral Pathol. 1991;71(6):675–7.

    CAS  Article  Google Scholar 

  11. 11.

    Manfredi R, Mazzoni A, Cavicchi O, Santini D, Chiodo F. Invasive mycotic and actinomycotic oropharyngeal and craniofacial infection in two patients with AIDS. Mycoses. 1994;37(5–6):209–15.

    CAS  Article  Google Scholar 

  12. 12.

    Kingdom TT, Tami TA. Actinomycosis of the nasal septum in a patient infected with the human immunodeficiency virus. Otolaryngol Neck Surg. 1994;111(1):130–3.

    CAS  Article  Google Scholar 

  13. 13.

    Manfredi R, Mazzoni A, Marinacci G, Nanetti A, Chiodo F. Progressive intractable actino mycosis in patients with AIDS. Scand J Infect Dis. 1995;1:405–7. https://doi.org/10.3109/00365549509032741.

    Article  Google Scholar 

  14. 14.

    Vazquez AM, Marti C, Reñaga I, Salavert A. Actinomycosis of the tongue associated with human immunodeficiency virus infection: case report. J Oral Maxillofac Surg. 1997;55(8):879–81.

    CAS  Article  Google Scholar 

  15. 15.

    Spadari F, Tartaglia GM, Spadari E, Fazio N. Oral actinomycosis in acquired immunode®ciency syndrome. Int J STD AIDS. 1998;9:424–6. https://doi.org/10.1258/0956462981922412.

    CAS  Article  PubMed  Google Scholar 

  16. 16.

    Ablanedo-Terrazas Y, Ormsby CE, Reyes-Terán G. Palatal actinomycosis and kaposi sarcoma in an HIV-infected subject with disseminated mycobacterium avium-intracellulare infection. Case Rep Med. 2012;2012:1–3.

    Article  Google Scholar 

  17. 17.

    Sudhakar SS, Ross JJ. Short-term treatment of actinomycosis: two cases and a review. Clin Infect Dis. 2004;38(3):444–7.

    Article  Google Scholar 

  18. 18.

    Klein M, Carrard VC, Munerato MC. Cervicofacial actinomycosis of the maxilla and HIV infection: a case report. Otolaryngology. 2017;07(01):1–4.

    Article  Google Scholar 

  19. 19.

    Cendan I, Klapholz A, Talavera W. A cause of endobronchial disease in a patient with AIDS. Chest. 1993;103(6):1886–7.

    CAS  Article  Google Scholar 

  20. 20.

    Tabarsi P, Yousefi S, Jabbehdari A, Sayena A, et al. Pulmonary actinomycosis in a patient with AIDS/HCV. J Clin Diagn Res. 2017;11(6):15–7.

    Google Scholar 

  21. 21.

    Spencer GM, Roach D, Skucas J. Actinomycosis of the esophagus in a patient with AIDS: findings on barium esophagograms. Am J Roentgenol. 1993;161(4):795–6.

    CAS  Article  Google Scholar 

  22. 22.

    Litt I, Levine S, Maki D, Sachdeva RM, Einhorn E. Ileal actinomycosis in a patient with AIDS. AJR. 1999;1:1297–9.

    Article  Google Scholar 

  23. 23.

    Arora AK, Nord J, Olofinlade O. Esophageal actinomycosis : a case report and review of the literature. Dysphagia. 2003;18(1):27–31.

    Article  Google Scholar 

  24. 24.

    Redelman-sidi G, Patel M, Dimaio C, et al. Esophageal actinomycosis in a fifty-three-year-old man. AIDS Patient Care STDS. 2010;24:2.

    Google Scholar 

  25. 25.

    Gomes J, Pereira T, Carvalho A, Brito C. Primary cutaneous actinomycosis caused by as first manifestation of HIV infection. Dermatol Online J. 2011;17:11.

    Google Scholar 

  26. 26.

    Abrahamian FM, Goldstein EJC. Microbiology of animal bite wound infections. Clin Microbiol Rev. 2011;24(2):231–46.

    Article  Google Scholar 

  27. 27.

    Metgud S. Primary cutaneous actinomycosis: A rare soft tissue infection. Indian J Med Microbiol. 2008;26(2):184–6. http://www.ijmm.org/article.asp?issn=0255-0857.

    CAS  Article  Google Scholar 

  28. 28.

    Roy D, Roy PG, Misra PK. An interesting case of primary cutaneous actinomycosis. Dermatol Online J. 2003;9(5). https://escholarship.org/uc/item/9x96h2pz#main.

  29. 29.

    Isenberg HD. Clinical microbiology procedures handbook. 2nd ed. Washington Dc: ASM Press; 2004.

    Google Scholar 

  30. 30.

    Georg LK, Robertstad GW, Brinkman SA. Identification of species of actinomyces. J Bacteriol. 1964;88(2):477–90.

    CAS  PubMed  PubMed Central  Google Scholar 

  31. 31.

    Robati RM, Niknezhad N, Bidari-Zerehpoush F, Niknezhad N. Primary cutaneous actinomycosis along with the surgical scar on the hand. Case Rep Infect Dis. 2016;2016:1–3.

    Google Scholar 

  32. 32.

    Booth SJ. Diseases caused by actinomyces species. In: Reference module in biomedical sciences. New York: Elsevier; 2014.

    Google Scholar 

  33. 33.

    Steininger C, Willinger B. Resistance patterns in clinical isolates of pathogenic Actinomyces species. J Antimicrob Chemother. 2016;71(2):422–7.

    CAS  Article  Google Scholar 

  34. 34.

    Akhtar M, Zade MP, Shahane PL, Bangde AP, Soitkar SM. Scalp actinomycosis presenting as soft tissue tumour: a case report with literature review. Int J Surg Case Rep. 2015;16:99–101. https://doi.org/10.1016/j.ijscr.2015.09.030.

    Article  PubMed  PubMed Central  Google Scholar 

  35. 35.

    S R. Australian Medicines Handbook. 2006th ed. Adelaide: Australian Medicines Handbook.

Download references

Acknowledgements

We would like to thanks Mr. Pradeep Sharma (Civil Service Hospital) his tremendous technical support.

Funding

No funding source.

Author information

Affiliations

Authors

Contributions

PK conceived the study, design the manuscript, review of the literature. SK reviewed the manuscript and gave the concept of the research paper and critically reviewed the manuscript. Both authors read and approved the final manuscript.

Corresponding author

Correspondence to Priyatam Khadka.

Ethics declarations

Ethics approval and consent to participate

There is no need for ethical approval for a case report according to the local ethical guidelines. Written informed consent was obtained from the patient for granting participation in an interview and to extract pertinent socio-demographic and clinical data from their respective clinical files, respecting confidentiality.

Consent for publication

Written informed consent was obtained from the patient for publication of this case report and any accompanying images.

Competing interest

The authors declare that they have no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Khadka, P., Koirala, S. Primary cutaneous actinomycosis: a diagnosis consideration in people living with HIV/AIDS. AIDS Res Ther 16, 16 (2019). https://doi.org/10.1186/s12981-019-0232-4

Download citation

Keywords

  • Diagnostic consideration
  • Penicillin
  • Primary cutaneous actinomycosis
  • AIDS